Global Oncology/Cancer Drugs Market Insights and Forecast to 2027

SKU ID : QYR-18086760 | Publishing Date : 23-Apr-2021 | No. of pages : 110

Detailed TOC of Global Oncology/Cancer Drugs Market Insights and Forecast to 2027

1 Study Coverage
    1.1 Oncology/Cancer Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Oncology/Cancer Drugs Market Size Growth Rate by Type
        1.4.2 Antimetabolite
        1.4.3 Alkaloid drugs
        1.2.4 Hormone
        1.2.5 Targeted drug
        1.2.6 Platinum-based drugs
        1.2.7 Other
    1.3 Market by Application
        1.3.1 Global Oncology/Cancer Drugs Market Size Growth Rate by Application
        1.3.2 Blood Cancer
        1.3.3 Breast Cancer
        1.3.4 Gastrointestinal Cancer
        1.3.5 Prostate Cancer
        1.3.6 Respiratory/Lung Cancer
        1.3.7 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Executive Summary
    2.1 Global Oncology/Cancer Drugs Sales Estimates and Forecasts 2016-2027
    2.2 Global Oncology/Cancer Drugs Revenue Estimates and Forecasts 2016-2027
    2.3 Global Oncology/Cancer Drugs Revenue by Region: 2016 VS 2021 VS 2027
    2.4 Global Top Oncology/Cancer Drugs Regions by Sales
        2.4.1 Global Top Oncology/Cancer Drugs Regions by Sales (2016-2021)
        2.4.2 Global Top Oncology/Cancer Drugs Regions by Sales (2022-2027)
    2.5 Global Top Oncology/Cancer Drugs Regions by Revenue
        2.5.1 Global Top Oncology/Cancer Drugs Regions by Revenue (2016-2021)
        2.5.2 Global Top Oncology/Cancer Drugs Regions by Revenue (2022-2027)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Oncology/Cancer Drugs Sales by Manufacturers
        3.1.1 Global Top Oncology/Cancer Drugs Manufacturers by Sales (2016-2021)
        3.1.2 Global Top Oncology/Cancer Drugs Manufacturers Market Share by Sales (2016-2021)
        3.1.3 Global Top 10 and Top 5 Companies by Oncology/Cancer Drugs Sales in 2020
    3.2 Global Oncology/Cancer Drugs Revenue by Manufacturers
        3.2.1 Global Top Oncology/Cancer Drugs Manufacturers by Revenue (2016-2021)
        3.2.2 Global Top Oncology/Cancer Drugs Manufacturers Market Share by Revenue (2016-2021)
        3.2.3 Global Top 10 and Top 5 Companies by Oncology/Cancer Drugs Revenue in 2020
    3.3 Global Oncology/Cancer Drugs Sales Price by Manufacturers
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Oncology/Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Oncology/Cancer Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
    4.1 Global Oncology/Cancer Drugs Sales by Type
        4.1.1 Global Oncology/Cancer Drugs Historical Sales by Type (2016-2021)
        4.1.2 Global Oncology/Cancer Drugs Forecasted Sales by Type (2022-2027)
        4.1.3 Global Oncology/Cancer Drugs Sales Market Share by Type (2016-2027)
    4.2 Global Oncology/Cancer Drugs Revenue by Type
        4.2.1 Global Oncology/Cancer Drugs Historical Revenue by Type (2016-2021)
        4.2.2 Global Oncology/Cancer Drugs Forecasted Revenue by Type (2022-2027)
        4.2.3 Global Oncology/Cancer Drugs Revenue Market Share by Type (2016-2027)
    4.3 Global Oncology/Cancer Drugs Price by Type
        4.3.1 Global Oncology/Cancer Drugs Price by Type (2016-2021)
        4.3.2 Global Oncology/Cancer Drugs Price Forecast by Type (2022-2027)
5 Market Size by Application
    5.1 Global Oncology/Cancer Drugs Sales by Application
        5.1.1 Global Oncology/Cancer Drugs Historical Sales by Application (2016-2021)
        5.1.2 Global Oncology/Cancer Drugs Forecasted Sales by Application (2022-2027)
        5.1.3 Global Oncology/Cancer Drugs Sales Market Share by Application (2016-2027)
    5.2 Global Oncology/Cancer Drugs Revenue by Application
        5.2.1 Global Oncology/Cancer Drugs Historical Revenue by Application (2016-2021)
        5.2.2 Global Oncology/Cancer Drugs Forecasted Revenue by Application (2022-2027)
        5.2.3 Global Oncology/Cancer Drugs Revenue Market Share by Application (2016-2027)
    5.3 Global Oncology/Cancer Drugs Price by Application
        5.3.1 Global Oncology/Cancer Drugs Price by Application (2016-2021)
        5.3.2 Global Oncology/Cancer Drugs Price Forecast by Application (2022-2027)

6 North America
    6.1 North America Oncology/Cancer Drugs Market Size by Type
        6.1.1 North America Oncology/Cancer Drugs Sales by Type (2016-2027)
        6.1.2 North America Oncology/Cancer Drugs Revenue by Type (2016-2027)
    6.2 North America Oncology/Cancer Drugs Market Size by Application
        6.2.1 North America Oncology/Cancer Drugs Sales by Application (2016-2027)
        6.2.2 North America Oncology/Cancer Drugs Revenue by Application (2016-2027)
    6.3 North America Oncology/Cancer Drugs Market Size by Country
        6.3.1 North America Oncology/Cancer Drugs Sales by Country (2016-2027)
        6.3.2 North America Oncology/Cancer Drugs Revenue by Country (2016-2027)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Oncology/Cancer Drugs Market Size by Type
        7.1.1 Europe Oncology/Cancer Drugs Sales by Type (2017-2027)
        7.1.2 Europe Oncology/Cancer Drugs Revenue by Type (2017-2027)
    7.2 Europe Oncology/Cancer Drugs Market Size by Application
        7.2.1 Europe Oncology/Cancer Drugs Sales by Application (2017-2027)
        7.2.2 Europe Oncology/Cancer Drugs Revenue by Application (2017-2027)
    7.3 Europe Oncology/Cancer Drugs Market Size by Country
        7.3.1 Europe Oncology/Cancer Drugs Sales by Country (2017-2027)
        7.3.2 Europe Oncology/Cancer Drugs Revenue by Country (2017-2027)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Oncology/Cancer Drugs Market Size by Type
        8.1.1 Asia Pacific Oncology/Cancer Drugs Sales by Type (2018-2027)
        8.1.2 Asia Pacific Oncology/Cancer Drugs Revenue by Type (2018-2027)
    8.2 Asia Pacific Oncology/Cancer Drugs Market Size by Application
        8.2.1 Asia Pacific Oncology/Cancer Drugs Sales by Application (2018-2027)
        8.2.2 Asia Pacific Oncology/Cancer Drugs Revenue by Application (2018-2027)
    8.3 Asia Pacific Oncology/Cancer Drugs Market Size by Region
        8.3.1 Asia Pacific Oncology/Cancer Drugs Sales by Region (2018-2027)
        8.3.2 Asia Pacific Oncology/Cancer Drugs Revenue by Region (2018-2027)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Oncology/Cancer Drugs Market Size by Type
        9.1.1 Latin America Oncology/Cancer Drugs Sales by Type (2019-2027)
        9.1.2 Latin America Oncology/Cancer Drugs Revenue by Type (2019-2027)
    9.2 Latin America Oncology/Cancer Drugs Market Size by Application
        9.2.1 Latin America Oncology/Cancer Drugs Sales by Application (2019-2027)
        9.2.2 Latin America Oncology/Cancer Drugs Revenue by Application (2019-2027)
    9.3 Latin America Oncology/Cancer Drugs Market Size by Country
        9.3.1 Latin America Oncology/Cancer Drugs Sales by Country (2019-2027)
        9.3.2 Latin America Oncology/Cancer Drugs Revenue by Country (2019-2027)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
6 Middle East and Africa
    6.1 Middle East and Africa Oncology/Cancer Drugs Market Size by Type
        6.1.1 Middle East and Africa Oncology/Cancer Drugs Sales by Type (2016-2027)
        6.1.2 Middle East and Africa Oncology/Cancer Drugs Revenue by Type (2016-2027)
    6.2 Middle East and Africa Oncology/Cancer Drugs Market Size by Application
        6.2.1 Middle East and Africa Oncology/Cancer Drugs Sales by Application (2016-2027)
        6.2.2 Middle East and Africa Oncology/Cancer Drugs Revenue by Application (2016-2027)
    6.3 Middle East and Africa Oncology/Cancer Drugs Market Size by Country
        6.3.1 Middle East and Africa Oncology/Cancer Drugs Sales by Country (2016-2027)
        6.3.2 Middle East and Africa Oncology/Cancer Drugs Revenue by Country (2016-2027)
        6.3.3 Turkey
        6.3.4 Saudi Arabia
        6.3.5 U.A.E

11 Company Profiles
    11.1 Roche
        11.1.1 Roche Corporation Information
        11.1.2 Roche Overview
        11.1.3 Roche Oncology/Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 Roche Oncology/Cancer Drugs Product Description
        11.1.5 Roche Related Developments
    11.2 HENGRUI
        11.2.1 HENGRUI Corporation Information
        11.2.2 HENGRUI Overview
        11.2.3 HENGRUI Oncology/Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.2.4 HENGRUI Oncology/Cancer Drugs Product Description
        11.2.5 HENGRUI Related Developments
    11.3 AstraZeneca
        11.3.1 AstraZeneca Corporation Information
        11.3.2 AstraZeneca Overview
        11.3.3 AstraZeneca Oncology/Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.3.4 AstraZeneca Oncology/Cancer Drugs Product Description
        11.3.5 AstraZeneca Related Developments
    11.4 QILU
        11.4.1 QILU Corporation Information
        11.4.2 QILU Overview
        11.4.3 QILU Oncology/Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.4.4 QILU Oncology/Cancer Drugs Product Description
        11.4.5 QILU Related Developments
    11.5 Sanofi
        11.5.1 Sanofi Corporation Information
        11.5.2 Sanofi Overview
        11.5.3 Sanofi Oncology/Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.5.4 Sanofi Oncology/Cancer Drugs Product Description
        11.5.5 Sanofi Related Developments
    11.6 HANSOH
        11.6.1 HANSOH Corporation Information
        11.6.2 HANSOH Overview
        11.6.3 HANSOH Oncology/Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.6.4 HANSOH Oncology/Cancer Drugs Product Description
        11.6.5 HANSOH Related Developments
    11.7 LUYE
        11.7.1 LUYE Corporation Information
        11.7.2 LUYE Overview
        11.7.3 LUYE Oncology/Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.7.4 LUYE Oncology/Cancer Drugs Product Description
        11.7.5 LUYE Related Developments
    11.8 Novartis
        11.8.1 Novartis Corporation Information
        11.8.2 Novartis Overview
        11.8.3 Novartis Oncology/Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.8.4 Novartis Oncology/Cancer Drugs Product Description
        11.8.5 Novartis Related Developments
    11.9 GuiZhou YiBai
        11.9.1 GuiZhou YiBai Corporation Information
        11.9.2 GuiZhou YiBai Overview
        11.9.3 GuiZhou YiBai Oncology/Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.9.4 GuiZhou YiBai Oncology/Cancer Drugs Product Description
        11.9.5 GuiZhou YiBai Related Developments
    11.10 Lunan
        11.10.1 Lunan Corporation Information
        11.10.2 Lunan Overview
        11.10.3 Lunan Oncology/Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.10.4 Lunan Oncology/Cancer Drugs Product Description
        11.10.5 Lunan Related Developments
    11.1 Roche
        11.1.1 Roche Corporation Information
        11.1.2 Roche Overview
        11.1.3 Roche Oncology/Cancer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 Roche Oncology/Cancer Drugs Product Description
        11.1.5 Roche Related Developments

12 Value Chain and Sales Channels Analysis
    12.1 Oncology/Cancer Drugs Value Chain Analysis
    12.2 Oncology/Cancer Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Oncology/Cancer Drugs Production Mode & Process
    12.4 Oncology/Cancer Drugs Sales and Marketing
        12.4.1 Oncology/Cancer Drugs Sales Channels
        12.4.2 Oncology/Cancer Drugs Distributors
    12.5 Oncology/Cancer Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Oncology/Cancer Drugs Industry Trends
    13.2 Oncology/Cancer Drugs Market Drivers
    13.3 Oncology/Cancer Drugs Market Challenges
    13.4 Oncology/Cancer Drugs Market Restraints

14 Key Findings in The Global Oncology/Cancer Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Figures, Tables and Charts Available in Global Oncology/Cancer Drugs Market Insights and Forecast to 2027

List of Tables
    Table 1. Global Oncology/Cancer Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Antimetabolite
    Table 3. Major Manufacturers of Alkaloid drugs
    Table 4. Major Manufacturers of Hormone
    Table 5. Major Manufacturers of Targeted drug
    Table 6. Major Manufacturers of Platinum-based drugs
    Table 7. Major Manufacturers of Other
    Table 8. Global Oncology/Cancer Drugs Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
    Table 9. Global Oncology/Cancer Drugs Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
    Table 10. Global Oncology/Cancer Drugs Sales by Region (2016-2021) & (K MT)
    Table 11. Global Oncology/Cancer Drugs Sales Market Share by Region (2016-2021)
    Table 12. Global Oncology/Cancer Drugs Sales by Region (2016-2021) & (K MT)
    Table 13. Global Oncology/Cancer Drugs Sales Market Share by Region (2022-2027)
    Table 14. Global Oncology/Cancer Drugs Revenue by Region (2016-2021) & (US$ Million)
    Table 15. Global Oncology/Cancer Drugs Revenue Market Share by Region (2016-2021)
    Table 16. Global Oncology/Cancer Drugs Revenue by Region (2022-2027) & (US$ Million)
    Table 17. Global Oncology/Cancer Drugs Revenue Market Share by Region (2022-2027)
    Table 18. Global Oncology/Cancer Drugs Sales by Manufacturers (2016-2021) & (K MT)
    Table 19. Global Oncology/Cancer Drugs Sales Share by Manufacturers (2016-2021)
    Table 20. Global Oncology/Cancer Drugs Revenue by Manufacturers (2016-2021) & (US$ Million)
    Table 21. Global Oncology/Cancer Drugs Revenue Share by Manufacturers (2016-2021)
    Table 22. Oncology/Cancer Drugs Price by Manufacturers 2016-2021 (USD/MT)
    Table 23. Global Oncology/Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global Oncology/Cancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology/Cancer Drugs as of 2020)
    Table 25. Oncology/Cancer Drugs Manufacturing Base Distribution and Headquarters
    Table 26. Manufacturers Oncology/Cancer Drugs Product Offered
    Table 27. Date of Manufacturers Enter into Oncology/Cancer Drugs Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Oncology/Cancer Drugs Sales by Type (2016-2021) & (K MT)
    Table 30. Global Oncology/Cancer Drugs Sales by Type (2022-2027) & (K MT)
    Table 31. Global Oncology/Cancer Drugs Sales Share by Type (2016-2021)
    Table 32. Global Oncology/Cancer Drugs Sales Share by Type (2022-2027)
    Table 33. Global Oncology/Cancer Drugs Revenue by Type (2016-2021) & (US$ Million)
    Table 34. Global Oncology/Cancer Drugs Revenue by Type (2022-2027) & (US$ Million)
    Table 35. Global Oncology/Cancer Drugs Revenue Share by Type (2016-2021)
    Table 36. Global Oncology/Cancer Drugs Revenue Share by Type (2022-2027)
    Table 37. Oncology/Cancer Drugs Price by Type (2016-2021) & (USD/MT)
    Table 38. Global Oncology/Cancer Drugs Price Forecast by Type (2022-2027) & (USD/MT)
    Table 39. Global Oncology/Cancer Drugs Sales by Application (2016-2021) & (K MT)
    Table 40. Global Oncology/Cancer Drugs Sales by Application (2022-2027) & (K MT)
    Table 41. Global Oncology/Cancer Drugs Sales Share by Application (2016-2021)
    Table 42. Global Oncology/Cancer Drugs Sales Share by Application (2022-2027)
    Table 43. Global Oncology/Cancer Drugs Revenue by Application (2016-2021) & (US$ Million)
    Table 44. Global Oncology/Cancer Drugs Revenue by Application (2022-2027) & (US$ Million)
    Table 45. Global Oncology/Cancer Drugs Revenue Share by Application (2016-2021)
    Table 46. Global Oncology/Cancer Drugs Revenue Share by Application (2022-2027)
    Table 47. Oncology/Cancer Drugs Price by Application (2016-2021) & (USD/MT)
    Table 48. Global Oncology/Cancer Drugs Price Forecast by Application (2022-2027) & (USD/MT)
    Table 49. North America Oncology/Cancer Drugs Sales by Type (2016-2021) & (K MT)
    Table 50. North America Oncology/Cancer Drugs Sales by Type (2022-2027) & (K MT)
    Table 51. North America Oncology/Cancer Drugs Revenue by Type (2016-2021) & (US$ Million)
    Table 52. North America Oncology/Cancer Drugs Revenue by Type (2022-2027) & (US$ Million)
    Table 53. North America Oncology/Cancer Drugs Sales by Application (2016-2021) & (K MT)
    Table 54. North America Oncology/Cancer Drugs Sales by Application (2022-2027) & (K MT)
    Table 55. North America Oncology/Cancer Drugs Revenue by Application (2016-2021) & (US$ Million)
    Table 56. North America Oncology/Cancer Drugs Revenue by Application (2022-2027) & (US$ Million)
    Table 57. North America Oncology/Cancer Drugs Sales by Country (2016-2021) & (K MT)
    Table 58. North America Oncology/Cancer Drugs Sales by Country (2022-2027) & (K MT)
    Table 59. North America Oncology/Cancer Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 60. North America Oncology/Cancer Drugs Revenue by Country (2022-2027) & (US$ Million)
    Table 61. Europe Oncology/Cancer Drugs Sales by Type (2016-2021) & (K MT)
    Table 62. Europe Oncology/Cancer Drugs Sales by Type (2022-2027) & (K MT)
    Table 63. Europe Oncology/Cancer Drugs Revenue by Type (2016-2021) & (US$ Million)
    Table 64. Europe Oncology/Cancer Drugs Revenue by Type (2022-2027) & (US$ Million)
    Table 65. Europe Oncology/Cancer Drugs Sales by Application (2016-2021) & (K MT)
    Table 66. Europe Oncology/Cancer Drugs Sales by Application (2022-2027) & (K MT)
    Table 67. Europe Oncology/Cancer Drugs Revenue by Application (2016-2021) & (US$ Million)
    Table 68. Europe Oncology/Cancer Drugs Revenue by Application (2022-2027) & (US$ Million)
    Table 69. Europe Oncology/Cancer Drugs Sales by Country (2016-2021) & (K MT)
    Table 70. Europe Oncology/Cancer Drugs Sales by Country (2022-2027) & (K MT)
    Table 71. Europe Oncology/Cancer Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 72. Europe Oncology/Cancer Drugs Revenue by Country (2022-2027) & (US$ Million)
    Table 73. Asia Pacific Oncology/Cancer Drugs Sales by Type (2016-2021) & (K MT)
    Table 74. Asia Pacific Oncology/Cancer Drugs Sales by Type (2022-2027) & (K MT)
    Table 75. Asia Pacific Oncology/Cancer Drugs Revenue by Type (2016-2021) & (US$ Million)
    Table 76. Asia Pacific Oncology/Cancer Drugs Revenue by Type (2022-2027) & (US$ Million)
    Table 77. Asia Pacific Oncology/Cancer Drugs Sales by Application (2016-2021) & (K MT)
    Table 78. Asia Pacific Oncology/Cancer Drugs Sales by Application (2022-2027) & (K MT)
    Table 79. Asia Pacific Oncology/Cancer Drugs Revenue by Application (2016-2021) & (US$ Million)
    Table 80. Asia Pacific Oncology/Cancer Drugs Revenue by Application (2022-2027) & (US$ Million)
    Table 81. Asia Pacific Oncology/Cancer Drugs Sales by Region (2016-2021) & (K MT)
    Table 82. Asia Pacific Oncology/Cancer Drugs Sales by Region (2022-2027) & (K MT)
    Table 83. Asia Pacific Oncology/Cancer Drugs Revenue by Region (2016-2021) & (US$ Million)
    Table 84. Asia Pacific Oncology/Cancer Drugs Revenue by Region (2022-2027) & (US$ Million)
    Table 85. Latin America Oncology/Cancer Drugs Sales by Type (2016-2021) & (K MT)
    Table 86. Latin America Oncology/Cancer Drugs Sales by Type (2022-2027) & (K MT)
    Table 87. Latin America Oncology/Cancer Drugs Revenue by Type (2016-2021) & (US$ Million)
    Table 88. Latin America Oncology/Cancer Drugs Revenue by Type (2022-2027) & (US$ Million)
    Table 89. Latin America Oncology/Cancer Drugs Sales by Application (2016-2021) & (K MT)
    Table 90. Latin America Oncology/Cancer Drugs Sales by Application (2022-2027) & (K MT)
    Table 91. Latin America Oncology/Cancer Drugs Revenue by Application (2016-2021) & (US$ Million)
    Table 92. Latin America Oncology/Cancer Drugs Revenue by Application (2022-2027) & (US$ Million)
    Table 93. Latin America Oncology/Cancer Drugs Sales by Country (2016-2021) & (K MT)
    Table 94. Latin America Oncology/Cancer Drugs Sales by Country (2022-2027) & (K MT)
    Table 95. Latin America Oncology/Cancer Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 96. Latin America Oncology/Cancer Drugs Revenue by Country (2022-2027) & (US$ Million)
    Table 97. Middle East and Africa Oncology/Cancer Drugs Sales by Type (2016-2021) & (K MT)
    Table 98. Middle East and Africa Oncology/Cancer Drugs Sales by Type (2022-2027) & (K MT)
    Table 99. Middle East and Africa Oncology/Cancer Drugs Revenue by Type (2016-2021) & (US$ Million)
    Table 100. Middle East and Africa Oncology/Cancer Drugs Revenue by Type (2022-2027) & (US$ Million)
    Table 101. Middle East and Africa Oncology/Cancer Drugs Sales by Application (2016-2021) & (K MT)
    Table 102. Middle East and Africa Oncology/Cancer Drugs Sales by Application (2022-2027) & (K MT)
    Table 103. Middle East and Africa Oncology/Cancer Drugs Revenue by Application (2016-2021) & (US$ Million)
    Table 104. Middle East and Africa Oncology/Cancer Drugs Revenue by Application (2022-2027) & (US$ Million)
    Table 105. Middle East and Africa Oncology/Cancer Drugs Sales by Country (2016-2021) & (K MT)
    Table 106. Middle East and Africa Oncology/Cancer Drugs Sales by Country (2022-2027) & (K MT)
    Table 107. Middle East and Africa Oncology/Cancer Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 108. Middle East and Africa Oncology/Cancer Drugs Revenue by Country (2022-2027) & (US$ Million)
    Table 109. Roche Corporation Information
    Table 110. Roche Description and Major Businesses
    Table 111. Roche Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 112. Roche Oncology/Cancer Drugs Product
    Table 113. Roche Recent Developments
    Table 114. HENGRUI Corporation Information
    Table 115. HENGRUI Description and Major Businesses
    Table 116. HENGRUI Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 117. HENGRUI Oncology/Cancer Drugs Product
    Table 118. HENGRUI Recent Developments
    Table 119. AstraZeneca Corporation Information
    Table 120. AstraZeneca Description and Major Businesses
    Table 121. AstraZeneca Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 122. AstraZeneca Oncology/Cancer Drugs Product
    Table 123. AstraZeneca Recent Developments
    Table 124. QILU Corporation Information
    Table 125. QILU Description and Major Businesses
    Table 126. QILU Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 127. QILU Oncology/Cancer Drugs Product
    Table 128. QILU Recent Developments
    Table 129. Sanofi Corporation Information
    Table 130. Sanofi Description and Major Businesses
    Table 131. Sanofi Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 132. Sanofi Oncology/Cancer Drugs Product
    Table 133. Sanofi Recent Developments
    Table 134. HANSOH Corporation Information
    Table 135. HANSOH Description and Major Businesses
    Table 136. HANSOH Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 137. HANSOH Oncology/Cancer Drugs Product
    Table 138. HANSOH Recent Developments
    Table 139. LUYE Corporation Information
    Table 140. LUYE Description and Major Businesses
    Table 141. LUYE Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 142. LUYE Oncology/Cancer Drugs Product
    Table 143. LUYE Recent Developments
    Table 144. Novartis Corporation Information
    Table 145. Novartis Description and Major Businesses
    Table 146. Novartis Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 147. Novartis Oncology/Cancer Drugs Product
    Table 148. Novartis Recent Developments
    Table 149. GuiZhou YiBai Corporation Information
    Table 150. GuiZhou YiBai Description and Major Businesses
    Table 151. GuiZhou YiBai Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 152. GuiZhou YiBai Oncology/Cancer Drugs Product
    Table 153. GuiZhou YiBai Recent Developments
    Table 154. Lunan Corporation Information
    Table 155. Lunan Description and Major Businesses
    Table 156. Lunan Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 157. Lunan Oncology/Cancer Drugs Product
    Table 158. Lunan Recent Developments
    Table 159. Eli Lilly and Company Corporation Information
    Table 160. Eli Lilly and Company Description and Major Businesses
    Table 161. Eli Lilly and Company Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 162. Eli Lilly and Company Oncology/Cancer Drugs Product
    Table 163. Eli Lilly and Company Recent Developments
    Table 164. Key Raw Materials Lists
    Table 165. Raw Materials Key Suppliers Lists
    Table 166. Oncology/Cancer Drugs Distributors List
    Table 167. Oncology/Cancer Drugs Customers List
    Table 168. Oncology/Cancer Drugs Market Trends
    Table 169. Oncology/Cancer Drugs Market Drivers
    Table 170. Oncology/Cancer Drugs Market Challenges
    Table 171. Oncology/Cancer Drugs Market Restraints
    Table 172. Research Programs/Design for This Report
    Table 173. Key Data Information from Secondary Sources
    Table 174. Key Data Information from Primary Sources
List of Figures
    Figure 1. Oncology/Cancer Drugs Product Picture
    Figure 2. Global Oncology/Cancer Drugs Market Share by Type in 2020 & 2027
    Figure 3. Antimetabolite Product Picture
    Figure 4. Alkaloid drugs Product Picture
    Figure 5. Hormone Product Picture
    Figure 6. Targeted drug Product Picture
    Figure 7. Platinum-based drugs Product Picture
    Figure 8. Other Product Picture
    Figure 9. Global Oncology/Cancer Drugs Sales Market Share by Application in 2020 & 2027
    Figure 10. Blood Cancer
    Figure 11. Breast Cancer
    Figure 12. Gastrointestinal Cancer
    Figure 13. Prostate Cancer
    Figure 14. Respiratory/Lung Cancer
    Figure 15. Other
    Figure 16. Oncology/Cancer Drugs Report Years Considered
    Figure 17. Global Oncology/Cancer Drugs Sales 2016-2027 (K MT)
    Figure 18. Global Oncology/Cancer Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 19. Global Oncology/Cancer Drugs Revenue 2016-2027 (US$ Million)
    Figure 20. Global Oncology/Cancer Drugs Revenue Market Share by Region in Percentage: 2020 Versus 2027
    Figure 21. Global Oncology/Cancer Drugs Sales Market Share by Region (2016-2021)
    Figure 22. Global Oncology/Cancer Drugs Sales Market Share by Region (2022-2027)
    Figure 23. North America Oncology/Cancer Drugs Sales YoY (2016-2027) & (K MT)
    Figure 24. North America Oncology/Cancer Drugs Revenue YoY (2016-2027) & (US$ Million)
    Figure 25. Europe Oncology/Cancer Drugs Sales YoY (2016-2027) & (K MT)
    Figure 26. Europe Oncology/Cancer Drugs Revenue YoY (2016-2027) & (US$ Million)
    Figure 27. Asia-Pacific Oncology/Cancer Drugs Sales YoY (2016-2027) & (K MT)
    Figure 28. Asia-Pacific Oncology/Cancer Drugs Revenue YoY (2016-2027) & (US$ Million)
    Figure 29. Latin America Oncology/Cancer Drugs Sales YoY (2016-2027) & (K MT)
    Figure 30. Latin America Oncology/Cancer Drugs Revenue YoY (2016-2027) & (US$ Million)
    Figure 31. Middle East & Africa Oncology/Cancer Drugs Sales YoY (2016-2027) & (K MT)
    Figure 32. Middle East & Africa Oncology/Cancer Drugs Revenue YoY (2016-2027) & (US$ Million)
    Figure 33. The Top 10 and Top 5 Players Market Share by Oncology/Cancer Drugs Sales in 2020
    Figure 34. The Top 10 and Top 5 Players Market Share by Oncology/Cancer Drugs Revenue in 2020
    Figure 35. Oncology/Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
    Figure 36. Global Oncology/Cancer Drugs Sales Market Share by Type (2016-2027)
    Figure 37. Global Oncology/Cancer Drugs Revenue Market Share by Type (2016-2027)
    Figure 38. Global Oncology/Cancer Drugs Sales Market Share by Application (2016-2027)
    Figure 39. Global Oncology/Cancer Drugs Revenue Market Share by Application (2016-2027)
    Figure 40. North America Oncology/Cancer Drugs Sales Market Share by Type (2016-2027)
    Figure 41. North America Oncology/Cancer Drugs Revenue Market Share by Type (2016-2027)
    Figure 42. North America Oncology/Cancer Drugs Sales Market Share by Application (2016-2027)
    Figure 43. North America Oncology/Cancer Drugs Revenue Market Share by Application (2016-2027)
    Figure 44. North America Oncology/Cancer Drugs Sales Share by Country (2016-2027)
    Figure 45. North America Oncology/Cancer Drugs Revenue Share by Country (2016-2027)
    Figure 46. U.S. Oncology/Cancer Drugs Revenue (2016-2027) & (US$ Million)
    Figure 47. Canada Oncology/Cancer Drugs Revenue (2016-2027) & (US$ Million)
    Figure 48. Europe Oncology/Cancer Drugs Sales Market Share by Type (2016-2027)
    Figure 49. Europe Oncology/Cancer Drugs Revenue Market Share by Type (2016-2027)
    Figure 50. Europe Oncology/Cancer Drugs Sales Market Share by Application (2016-2027)
    Figure 51. Europe Oncology/Cancer Drugs Revenue Market Share by Application (2016-2027)
    Figure 52. Europe Oncology/Cancer Drugs Sales Share by Country (2016-2027)
    Figure 53. Europe Oncology/Cancer Drugs Revenue Share by Country (2016-2027)
    Figure 54. Germany Oncology/Cancer Drugs Revenue (2016-2027) & (US$ Million)
    Figure 55. France Oncology/Cancer Drugs Revenue (2016-2027) & (US$ Million)
    Figure 56. U.K. Oncology/Cancer Drugs Revenue (2016-2027) & (US$ Million)
    Figure 57. Italy Oncology/Cancer Drugs Revenue (2016-2027) & (US$ Million)
    Figure 58. Russia Oncology/Cancer Drugs Revenue (2016-2027) & (US$ Million)
    Figure 59. Asia Pacific Oncology/Cancer Drugs Sales Market Share by Type (2016-2027)
    Figure 60. Asia Pacific Oncology/Cancer Drugs Revenue Market Share by Type (2016-2027)
    Figure 61. Asia Pacific Oncology/Cancer Drugs Sales Market Share by Application (2016-2027)
    Figure 62. Asia Pacific Oncology/Cancer Drugs Revenue Market Share by Application (2016-2027)
    Figure 63. Asia Pacific Oncology/Cancer Drugs Sales Share by Region (2016-2027)
    Figure 64. Asia Pacific Oncology/Cancer Drugs Revenue Share by Region (2016-2027)
    Figure 65. China Oncology/Cancer Drugs Revenue (2016-2027) & (US$ Million)
    Figure 66. Japan Oncology/Cancer Drugs Revenue (2016-2027) & (US$ Million)
    Figure 67. South Korea Oncology/Cancer Drugs Revenue (2016-2027) & (US$ Million)
    Figure 68. India Oncology/Cancer Drugs Revenue (2016-2027) & (US$ Million)
    Figure 69. Australia Oncology/Cancer Drugs Revenue (2016-2027) & (US$ Million)
    Figure 70. Taiwan Oncology/Cancer Drugs Revenue (2016-2027) & (US$ Million)
    Figure 71. Indonesia Oncology/Cancer Drugs Revenue (2016-2027) & (US$ Million)
    Figure 72. Thailand Oncology/Cancer Drugs Revenue (2016-2027) & (US$ Million)
    Figure 73. Malaysia Oncology/Cancer Drugs Revenue (2016-2027) & (US$ Million)
    Figure 74. Philippines Oncology/Cancer Drugs Revenue (2016-2027) & (US$ Million)
    Figure 75. Latin America Oncology/Cancer Drugs Sales Market Share by Type (2016-2027)
    Figure 76. Latin America Oncology/Cancer Drugs Revenue Market Share by Type (2016-2027)
    Figure 77. Latin America Oncology/Cancer Drugs Sales Market Share by Application (2016-2027)
    Figure 78. Latin America Oncology/Cancer Drugs Revenue Market Share by Application (2016-2027)
    Figure 79. Latin America Oncology/Cancer Drugs Sales Share by Country (2016-2027)
    Figure 80. Latin America Oncology/Cancer Drugs Revenue Share by Country (2016-2027)
    Figure 81. Mexico Oncology/Cancer Drugs Revenue (2016-2027) & (US$ Million)
    Figure 82. Brazil Oncology/Cancer Drugs Revenue (2016-2027) & (US$ Million)
    Figure 83. Argentina Oncology/Cancer Drugs Revenue (2016-2027) & (US$ Million)
    Figure 84. Middle East and Africa Oncology/Cancer Drugs Sales Market Share by Type (2016-2027)
    Figure 85. Middle East and Africa Oncology/Cancer Drugs Revenue Market Share by Type (2016-2027)
    Figure 86. Middle East and Africa Oncology/Cancer Drugs Sales Market Share by Application (2016-2027)
    Figure 87. Middle East and Africa Oncology/Cancer Drugs Revenue Market Share by Application (2016-2027)
    Figure 88. Middle East and Africa Oncology/Cancer Drugs Sales Share by Country (2016-2027)
    Figure 89. Middle East and Africa Oncology/Cancer Drugs Revenue Share by Country (2016-2027)
    Figure 90. Turkey Oncology/Cancer Drugs Revenue (2016-2027) & (US$ Million)
    Figure 91. Saudi Arabia Oncology/Cancer Drugs Revenue (2016-2027) & (US$ Million)
    Figure 92. U.A.E Oncology/Cancer Drugs Revenue (2016-2027) & (US$ Million)
    Figure 93. Oncology/Cancer Drugs Value Chain
    Figure 94. Oncology/Cancer Drugs Production Process
    Figure 95. Channels of Distribution
    Figure 96. Distributors Profiles
    Figure 97. Bottom-up and Top-down Approaches for This Report
    Figure 98. Data Triangulation
    Figure 99. Key Executives Interviewed